This appears to be as well controlled a study as possible. The authors cover the
potential limitations in their discussion. Their conclusion that the increased cost of
CSII is not justified by improved clinical outcomes is convincing.
Table 2. Change in BMI SDS for mean CSII and height SDS for mean CSII and mean
MDI are not correct. Confidence intervals for mean CSII and MDI only given for
HbA1c?
In table 4, "Other hospital e.g. ward visits".Why is the difference 1 when the number
of visits is the same between the groups
